Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02669407 · ClinicalTrials.gov registry record · NA
Splanchnic Nerve Anesthesia in Heart Failure
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02669407: Completed NA study, sponsored by Duke University.
NCT02669407 is a NA study that has completed, run by Duke University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02669407, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Patients admitted for acute heart failure and undergoing right heart catheterization will be enrolled in this study. Subjects will undergo catheterization of the heart to obtain central cardiac pressure and other cardiac hemodynamic parameters. Subsequently, the subject will undergo a regional nerve block of the splanchnic nerves. Patients will remain in the catheterization lab for the duration of anesthetic block and will be continuously hemodynamically monitored. This study will be a prospective, uncontrolled clinical trial. The study will not be controlled as invasive monitoring of hemodynamics will be performed, allowing clear demonstration of a cause-effect relationship. The goal of the study is to provide proof of concept.
Interventions
- PROCEDURE splanchnic nerve anesthesia with a local anesthetic
- DRUG regional nerve block with a local anesthetic (Lidocaine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02669407 record still lists
NCT02669407 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which splanchnic nerve anesthesia with a local anesthetic is the first listed.
NCT02669407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02669407 about?
NCT02669407 is a clinical study titled "Splanchnic Nerve Anesthesia in Heart Failure". Patients admitted for acute heart failure and undergoing right heart catheterization will be enrolled in this study. Subjects will undergo catheterization of the heart to obtain central cardiac pressure and other cardiac hemodynamic parameters. Subsequently, the subject will undergo a regional nerve...
What is the current status of trial NCT02669407?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2017-01-01. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02669407?
The interventions under investigation include: splanchnic nerve anesthesia with a local anesthetic (PROCEDURE), regional nerve block with a local anesthetic (Lidocaine) (DRUG).
Who is sponsoring clinical trial NCT02669407?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02669407's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy